Tarsus Names José Trevejo, MD, PhD, As Chief Medical Officer

José Trevejo, MD, PhD, has been named Chief Medical Officer of Tarsus Pharmaceuticals. Dr. Trevejo has more than 20 years of experience in clinical development of novel treatments for serious diseases.

Tarsus Names José Trevejo, MD, PhD, As Chief Medical Officer
February 04, 2022
Eyenovia Announces Changes to Board of Directors

Eyenovia has made changes to its Board of Directors.

Eyenovia Announces Changes to Board of Directors
February 08, 2022
Outlook Therapeutics Expands Commercial Team with New Appointment

Joel Prieve has been named Senior Vice President, Commercial Operations at Outlook Therapeutics, which is working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal diseases.

Outlook Therapeutics Expands Commercial Team with New Appointment
February 09, 2022
Spark Therapeutics’ CEO and Founder Jeff Marrazzo Steps Down, COO Ron Philip to Succeed

Spark Therapeutics, a part of the Roche Group, announced that Ron Philip, the company's COO, will take over as CEO from co-founder Jeffrey D. Marrazzo. Mr. Marrazzo, who joined the company as a co-founder in 2013, will step down on April 1.

Spark Therapeutics’ CEO and Founder Jeff Marrazzo Steps Down, COO Ron Philip to Succeed
February 25, 2022
Tarsus Announces the Appointment of Elizabeth Yeu, MD, to its Board of Directors

Tarsus Pharmaceuticals announced that Elizabeth Yeu, MD, has been appointed to its Board of Directors. Dr. Yeu will continue to serve as the company’s Chief Medical Advisor.

Tarsus Announces the Appointment of Elizabeth Yeu, MD, to its Board of Directors
January 05, 2022
BRIM Biotechnology Enters OTC Trading in Taiwan

BRIM Biotechnology has entered OTC trading in Taiwan on June 23, 2022. Established in 2013, BRIM is a clinical-stage company developing novel regenerative therapies to help combat and cure ophthalmology and degenerative joint diseases.

BRIM Biotechnology Enters OTC Trading in Taiwan
June 29, 2022
RxSight Welcomes Tamara R. Fountain, MD, and Shweta Singh Maniar to its Board of Directors

RxSight welcomes Tamara R. Fountain, MD, and Shweta Singh Maniar into its Board of Directors.

RxSight Welcomes Tamara R. Fountain, MD, and Shweta Singh Maniar to its Board of Directors
January 07, 2022
Evmann Creates Roadmap to Facilitate its Development into a Global Unicorn Company

Dutch Evmann Investments Holding, the parent company of VSY Biotechnology GmbH and Alsanza Medizintechnik und Pharma GmbH, organized its 2022 Global Leadership Meeting last week in line with its strategic plans to become a Unicorn company.

Evmann Creates Roadmap to Facilitate its Development into a Global Unicorn Company
March 24, 2022
Oyster Point Pharma Reveals Restructuring Plan to Reduce Expenses

Oyster Point Pharma announced it will implement an operating expense streamlining plan that will include a reduction of employee and non-employee expenses across the organization.

Oyster Point Pharma Reveals Restructuring Plan to Reduce Expenses
July 04, 2022
Euclid Vision Announces Acquisition of Visionary Optics

Euclid Vision, formerly Euclid Systems, has announced its acquisition of Visionary Optics, a specialty scleral contact lens design and distribution company.

Euclid Vision Announces Acquisition of Visionary Optics
April 21, 2022
Daha fazla